Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05687942
Other study ID # CTP-0002
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 2023
Est. completion date June 2026

Study information

Verified date January 2023
Source AbSolutions Med Inc.
Contact Dan Jacobs, MD
Phone 650-303-6140
Email djacobs@absolutionsmed.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main objective of this clinical trial is to demonstrate the safety and efficacy of REBUILD when used to support abdominal wall closure after laparotomy. The main question it aims to answer are whether the device when used to support suture in abdominal wall closure safely maintains apposition of the abdominis rectus muscles within a pre-defined distance. Participants will undergo standard of care laparotomy and the investigational device will be used to support the suture used to close the abdominal wall. Participants will have an MRI at 1-month after surgery to measure the distance between the abdominus rectus muscles.


Description:

The REBUILD Trial (Protocol CTP-0002) is an investigational medical device study designed to demonstrate the efficacy and safety of REBUILD for abdominal wall closure (AWC). The primary evaluation period will include the first 30 days of follow up. After the 1-month endpoint evaluation period, additional follow-up at 3, 6, 12, and 24-months for post-market analysis and publication will be conducted. All adverse events will be collected and reported for the full duration of the study. - Primary efficacy endpoint will be evaluated based on the measured distance between the rectus abdominis muscles (RAMs) by MRI at 1-month (Day 30 +14/-7 days) post-surgery (Day 0). - Primary safety endpoint will be evaluated based on reported serious device-related adverse events through 1-month (Day 30 +14/-7 days) of follow-up.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 40
Est. completion date June 2026
Est. primary completion date September 2024
Accepts healthy volunteers No
Gender All
Age group 22 Years to 80 Years
Eligibility Inclusion Criteria: 1. Patient is 22-80 years of age 2. Patient is undergoing a midline laparotomy procedure 3. Patient is able to provide written informed consent 4. Patient is able and willing to comply with all study requirements Exclusion Criteria: 1. Patient has BMI > 40 2. Patients with available imaging measuring abdominal wall thickness < 5.7 mm or > 16.5 mm 3. Patient is scheduled for a palliative procedure or has a life expectancy of less than 12-months 4. Patient has mesh at the site of deployment 5. Patient has an ostomy within the planned midline closure site (4 cm either side of midline) 6. Patient has a CDC wound classification of Class IV 7. Patient has devitalized tissue present at the intended surgical site 8. Patient has any co-morbid conditions determined by the investigator to place them at a high risk of complications (e.g., severe cardiovascular disease, congestive heart failure NYHA Class III or IV, end-stage renal failure, liver cirrhosis, connective tissue disorder, poorly managed diabetes) 9. Patient is on any medication that the investigator determines creates a high risk for complications (e.g., antithrombotic, steroid, IV chemotherapy, immunosuppressive agent) 10. Patient has history of radiation therapy targeting the abdominal wall 11. Patient is participating in a concurrent investigational medical device study 12. Patient is pregnant or planning on becoming pregnant during the study period 13. Patient has a history of psychological condition, drug, or alcohol misuse which may interfere with their ability to be compliant with post-operative visits

Study Design


Related Conditions & MeSH terms


Intervention

Device:
REBUILD
3.1.1. REBUILD is an investigational medical device provided as a sterile, single use set containing 10 suture Anchors and two non-implantable Carriers, with reusable stainless-steel instruments for deployment supplied separately.

Locations

Country Name City State
Israel Rambam Health Care Campus Haifa

Sponsors (2)

Lead Sponsor Collaborator
AbSolutions Med Inc. Cogent Technologies Corporation

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Efficacy Measure distance between the rectus abdominus muscles The primary efficacy endpoint is a maximum distance between the RAMs at 1-month after surgery < 2.5 cm (binary outcome). Day 30 (+14/-7 days)
Primary Serious device related adverse events The primary safety endpoint is serious device-related adverse events through 1-month follow-up. Day 30 (+14/-7 days)
See also
  Status Clinical Trial Phase
Recruiting NCT06202053 - An Observational Study on the Quality of Life After Precise Lung Resection Through the Periareolar Incision
Terminated NCT05234632 - Study to Evaluate the PICO 14 Negative Pressure Wound Therapy System in the Management of Acute and Chronic Wounds N/A
Completed NCT04888624 - A Comparison Between Two Post-operative Dressings N/A
Recruiting NCT05897723 - Fractional Radiofrequency for Reduction of Surgical Scar Formation N/A
Recruiting NCT03561376 - Zinc Oxide Versus Petrolatum Following Skin Surgery Early Phase 1
Active, not recruiting NCT05028816 - Force Modulating Tissue Bridges for Closure of Vertical Scars in Breast Reduction N/A
Terminated NCT03688880 - A Clinical Study to Compare MAR-CUTIS With Dermabond Advanced N/A
Recruiting NCT02989363 - Evaluation of the Use of Resources and Costs N/A
Completed NCT03199911 - Topical Antibiotic Prophylaxis for Eyelids Phase 4
Completed NCT05618912 - Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment N/A
Withdrawn NCT04053946 - Clinical Assessment of Next Science Wound Gels in Healing Below the Knee Amputation Surgical Wound Compared to SOC N/A
Enrolling by invitation NCT05461157 - Preoperative Silicone Ointment and Wound Healing N/A
Completed NCT04336371 - Exploratory Prospective of Experienced by Patients in the Surgery of Skin Cancers of the Face in Interventional Dermatology Department
Not yet recruiting NCT04250649 - Does Disinfection of the Subcutaneous Tissue Reduce Contamination of the Operating Field With P. Acnes? N/A
Completed NCT03860181 - Dermabond PRINEO for Total Shoulder Arthroplasty N/A
Enrolling by invitation NCT03180346 - A Prospective, Randomized, Comparative Study to Assess the Prevention of Surgical Site Infection (SSI's) in Revision Total Joint Arthroplasty Patients Treated With Single-Use Negative Pressure Wound Therapy (PICO) or Standard Care Dressings (AQUACEL Ag SURGICAL Dressing). N/A
Completed NCT02977221 - Efficacy of Piezosurgey Corticotomy (a Minimally Invasive Surgical Technique) in Accelerating Orthodontic Alignment N/A
Completed NCT02975765 - Evaluation of the Levels of Pain and Discomfort Between Two Methods of Correcting Misaligned Teeth N/A
Completed NCT06047418 - Blepharoptosis in Indonesia: A 5-Year Multicenter Study on Characteristics and Surgical Evaluation
Not yet recruiting NCT04894604 - A Safety and Performance PMCF Investigation of the Avance® Solo NPWT System in Surgically Closed Incisions N/A